Factors Influencing Clostridium difficile Infection Risk After Stoma Reversal in TaTME Surgery
Overview
This retrospective cohort study evaluated the incidence of Clostridium difficile infection (CDI) following stoma reversal in patients undergoing Transanal Total Mesorectal Excision (TaTME) for rectal cancer. The study identified clinical variables associated with increased CDI risk and utilized machine learning models to predict postoperative diarrhea and CDI occurrence.
Background
Clostridium difficile infection is a common healthcare-associated infection, particularly prevalent after colon surgery and stoma reversal. CDI can cause severe complications such as toxic megacolon and has increasing incidence and severity. Diagnosis is challenging post-stoma reversal due to frequent diarrhea from other causes like diversion colitis. Identifying patients at higher risk for CDI after TaTME and stoma reversal is critical for improving postoperative management.
Data Highlights
The study included patients undergoing TaTME with diverting stoma and subsequent stoma reversal between 2015 and 2023. CDI diagnosis was based on stool testing for C. difficile toxin A/B and GDH antigen, with confirmatory nucleic acid amplification tests as needed. Clinical variables analyzed included age, sex, BMI, Charlson index, albuminemia, neoadjuvant and adjuvant therapies, ASA score, and time to stoma reversal. Statistical analyses and supervised machine learning models (Random Forest and Naïve Bayes) were applied to identify predictors of CDI and postoperative diarrhea.
Key Findings
The incidence of CDI after stoma reversal in patients undergoing TaTME was higher than in the general population and other colon surgeries.
Risk factors for CDI included older age, prolonged hospitalization, antibiotic use, proton pump inhibitor use, and immunosuppression.
Postoperative diarrhea exceeding 10 stools per day prompted CDI testing, improving early detection.
Machine learning models, particularly Random Forest, showed promise in predicting patients at risk for CDI and postoperative diarrhea based on clinical variables.
Neoadjuvant chemoradiotherapy and timing of stoma reversal were important variables considered in risk stratification.
Clinical Implications
Clinicians should maintain a high index of suspicion for CDI in patients undergoing stoma reversal after TaTME, especially those with known risk factors. Early testing for CDI in patients with significant postoperative diarrhea can facilitate prompt diagnosis and treatment. Incorporating predictive models may help identify high-risk patients and tailor perioperative management to reduce CDI incidence.
Conclusion
CDI is a significant postoperative complication following stoma reversal in TaTME patients, with identifiable risk factors and potential for prediction using machine learning. Awareness and early intervention are essential to improve patient outcomes.
References
1 -- Clostridium difficile Infection Epidemiology and Risk Factors
2 -- Clostridium difficile Pathogenesis and Clinical Impact
3 -- Increasing Incidence and Severity of CDI Since 1970s
4 -- CDI Incidence After Colon Surgery and Stoma Reversal
5 -- Diagnostic Criteria for Clostridium difficile Infection
6 -- Diarrhea and Diversion Colitis After Stoma Reversal
